Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy.

Carolin MuellerGilda SchmidtIngolf Juhasz-BössLisa JungSarah HuwerErich-Franz SolomayerStephanie Juhasz-Böss
Published in: Archives of gynecology and obstetrics (2021)
Particularly patients with high risk cancer and patients, participating in clinical trials benefit most from chemotherapy. Therefore, breast cancer patients can be encouraged to participate in clinical trials for chemotherapy.